SUMMARY
This is AI generated summarization, which may have errors. For context, always refer to the full article.
Naturally occurring human gene sequences cannot be patented but artificially copied and replicated DNA can be, the US Supreme Court ruled on June 13. “A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated but cDNA is patent eligible because it is not naturally occurring,” the court ruled. The nine justices reviewed a 2012 appeals court decision that allowed a biotechnology company, Myriad Genetics Inc, to patent two genes it found had links to breast and ovarian cancer.
Read the full story on Rappler.
Add a comment
How does this make you feel?
Loading
There are no comments yet. Add your comment to start the conversation.